This inventor holds 2 USPTO granted patents. Top assignees: Fujisawa Pharmaceutical Company, Ltd., Fujisawa Pharmaceutical., Ltd.. Active years: 2001-2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2001-2002
Title: The Innovations of Fusako Nishigaki
Introduction
Fusako Nishigaki is a notable inventor based in Osaka, Japan. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that have therapeutic applications. With a total of 2 patents, her work has the potential to impact the treatment of cartilage damage and vascular permeability issues.
Latest Patents
Nishigaki's latest patents include innovative solutions for medical challenges. One of her patents focuses on macrolide compounds for inducing chondrogenic differentiation. This method involves administering a macrocyclic lactone to mammals to prevent or treat damage to cartilage. Another patent addresses vascular permeability suppressants, which include an oxaspirooctane derivative designed to enhance vascular stability.
Career Highlights
Throughout her career, Fusako Nishigaki has worked with prominent companies in the pharmaceutical industry. She has been associated with Fujisawa Pharmaceutical, Ltd. and Fujisawa Pharmaceutical Company, Ltd., where she contributed to various research and development projects. Her expertise in the field has led to advancements in drug formulations and therapeutic strategies.
Collaborations
Nishigaki has collaborated with esteemed colleagues, including Susumu Miyata and Toshitaka Manda. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Fusako Nishigaki's contributions to the pharmaceutical industry through her patents and collaborations highlight her role as a significant inventor. Her work continues to pave the way for advancements in medical treatments, particularly in cartilage repair and vascular health.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile